<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The laboratory assessment of the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, a factor frequently associated with venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriages</z:e> and abortions, is not straightforward, as indicated by the variety of tests proposed and the different results obtained </plain></SENT>
<SENT sid="1" pm="."><plain>On account of the marked variability and <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> among patients, no single test or reagent will identify <z:hpo ids='HP_0000001'>all</z:hpo> patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, and a panel of several tests has to be used </plain></SENT>
<SENT sid="2" pm="."><plain>This is time consuming and increases the workload of the laboratory </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to assess the minimum number of tests necessary for the satisfactory identification of the patient with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Our study confirms that <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> may be present in a significant number of patients with <z:mpath ids='MPATH_458'>normal</z:mpath> routine activated partial thromboplastin time, a test which therefore cannot be used as the sole criterion for identifying patients suspected of having <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast <z:hpo ids='HP_0000001'>all</z:hpo> patients who had positive results in at least one test could be detected (100% sensitivity) with two combinations of tests: (1) dilute activated partial thromboplastin time and Kaolin clotting time and (2) dilute activated partial thromboplastin time and tissue thromboplastin inhibition test </plain></SENT>
<SENT sid="6" pm="."><plain>Since the latter inhibition test has been reported to give a high number of false-positive or negative results, we suggest the combination of dilute activated partial thromboplastin time and Kaolin clotting time as the standard pair of tests for the screening of suspected <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> patients </plain></SENT>
</text></document>